Boothbay Fund Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Sell |
318,819
-218,400
| -41% | -$118K | ﹤0.01% | 1075 |
|
|
2025
Q1 | $352K | Hold |
537,219
| – | – | 0.01% | 833 |
|
|
2024
Q4 | $548K | Buy |
+537,219
| New | +$548K | 0.01% | 702 |
|
|
2020
Q2 | – | Sell |
-11,100
| Closed | -$71K | – | 973 |
|
|
2020
Q1 | $71K | Buy |
+11,100
| New | +$71K | 0.01% | 669 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 798 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 777 |
|
|
2018
Q3 | – | Sell |
-25,600
| Closed | -$364K | – | 812 |
|
|
2018
Q2 | $364K | Buy |
+25,600
| New | +$364K | 0.03% | 310 |
|